Collections
This file is in the following collections:
| Pediatric Neurology Briefs: Volume 20, Issue 02 |
Trial of Immune Globulin in Infant Botulism Open Access (recommended)
Descriptions
- Resource type(s)
- Article
- Keyword
- Infant Botulism
Werdnig Hoffman
Human Botulism Immune Globulin Intravenous
- Rights
- Attribution 4.0 International
- Creator
-
Millichap, J. Gordon
- Abstract
-
A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by type B toxin) was conducted at the California Department of Health Services, Richmond, CA; National Botulism Surveillance and Reference Laboratory, CDC and P, Atlanta; and Division of Biostatistics, University of California, Berkeley.
- Publisher
-
DigitalHub. Galter Health Sciences Library
Pediatric Neurology Briefs Publishers
- Date Created
-
2006
- Original Identifier
- PNB-20-13
- Language
- English
- Subject: MESH
-
Infant
Child Development
Neurosurgery
Nervous System Diseases
Child
Pediatrics
Neurology
Brain Diseases
- DOI
-
10.15844/pedneurbriefs-20-2-5
File Details
- File Properties
-
Mime type: application/pdf
File size: 1241.7 kB